LENACAPAVIR SODIUM

LENACAPAVIR SODIUM was reported 506 times

These side effects are most commonly reported by patients taking LENACAPAVIR SODIUM:

# Side effect Count
0 INJECTION SITE DISCHARGE 149
1 INJECTION SITE PAIN 141
2 INJECTION SITE NODULE 113
3 INJECTION SITE ERYTHEMA 43
4 INJECTION SITE MASS 37
5 INJECTION SITE SWELLING 24
6 INJECTION SITE CELLULITIS 17
7 LOSS OF CONSCIOUSNESS 16
8 INJECTION SITE BRUISING 15
9 INJECTION SITE REACTION 14
10 SYNCOPE 13
11 NAUSEA 12
12 VOMITING 12
13 DIZZINESS 10
14 INJECTION SITE DISCOMFORT 10
15 INJECTION SITE HAEMORRHAGE 9
16 PAIN 9
17 PRESYNCOPE 9
18 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9
19 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7
20 INJECTION SITE INFECTION 7
21 INJECTION SITE ULCER 7
22 MUSCLE SPASMS 7
23 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 7
24 HEADACHE 6
25 HYPERHIDROSIS 6
26 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6
27 INJECTION SITE ABSCESS 6
28 INJECTION SITE PARAESTHESIA 6
29 PYREXIA 6
30 ABDOMINAL PAIN 5
31 INCORRECT DOSE ADMINISTERED 5
32 INJECTION SITE INFLAMMATION 5
33 INJECTION SITE PRURITUS 5
34 INJECTION SITE WARMTH 5
35 MYALGIA 5
36 PRODUCT STORAGE ERROR 5
37 ABDOMINAL PAIN UPPER 4
38 CHILLS 4
39 DYSPNOEA 4
40 FATIGUE 4
41 GAIT DISTURBANCE 4
42 INJECTION SITE INDURATION 4
43 INJECTION SITE IRRITATION 4
44 OFF LABEL USE 4
45 PRODUCT USE IN UNAPPROVED INDICATION 4
46 PRODUCT USE ISSUE 4
47 SEIZURE 4
48 SWELLING 4
49 TENDERNESS 4
50 TREMOR 4
51 URTICARIA 4
52 ABDOMINAL DISCOMFORT 3
53 ANXIETY 3
54 ARTHRALGIA 3
55 BACK PAIN 3
56 DIARRHOEA 3
57 DRUG INTERACTION 3
58 INJECTION SITE DISCOLOURATION 3
59 INJECTION SITE HYPOAESTHESIA 3
60 INSOMNIA 3
61 MATERNAL EXPOSURE DURING PREGNANCY 3
62 NODULE 3
63 PALPITATIONS 3
64 PRURITUS 3
65 ABDOMINAL DISTENSION 2
66 ACCIDENTAL UNDERDOSE 2
67 ADMINISTRATION SITE WOUND 2
68 ANAL GONOCOCCAL INFECTION 2
69 CELLULITIS 2
70 DECREASED APPETITE 2
71 DISCOMFORT 2
72 DRUG INEFFECTIVE 2
73 ERYTHEMA 2
74 EXTRA DOSE ADMINISTERED 2
75 EYE MOVEMENT DISORDER 2
76 GASTROINTESTINAL PAIN 2
77 HIV TEST POSITIVE 2
78 HYPERTRANSAMINASAEMIA 2
79 HYPOAESTHESIA 2
80 INJECTION SITE HYPERSENSITIVITY 2
81 INJECTION SITE RASH 2
82 INTENTIONAL PRODUCT USE ISSUE 2
83 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2
84 LYMPHADENOPATHY 2
85 MOVEMENT DISORDER 2
86 NASOPHARYNGITIS 2
87 NIGHT SWEATS 2
88 NO ADVERSE EVENT 2
89 PAIN IN EXTREMITY 2
90 PRODUCT DOSE OMISSION ISSUE 2
91 RASH 2
92 SKIN EXFOLIATION 2
93 SOMNOLENCE 2
94 SURGERY 2
95 UNEVALUABLE EVENT 2
96 URINARY INCONTINENCE 2
97 ABDOMINAL MASS 1
98 ABDOMINAL TENDERNESS 1
99 ABDOMINAL WALL WOUND 1
100 ACUTE HIV INFECTION 1
101 ACUTE KIDNEY INJURY 1
102 ADMINISTRATION SITE DISCHARGE 1
103 ANHEDONIA 1
104 APPENDICITIS NONINFECTIVE 1
105 ASTHENIA 1
106 BLOOD BILIRUBIN INCREASED 1
107 BLOOD CHOLESTEROL DECREASED 1
108 BODY DYSMORPHIC DISORDER 1
109 BODY TEMPERATURE INCREASED 1
110 BRAIN NEOPLASM MALIGNANT 1
111 BREAST CANCER 1
112 CARDIO-RESPIRATORY ARREST 1
113 CEREBROVASCULAR ACCIDENT 1
114 CHOKING 1
115 CHOLELITHIASIS 1
116 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1
117 COLD SWEAT 1
118 CONDITION AGGRAVATED 1
119 CONTUSION 1
120 COUGH 1
121 CYTOKINE RELEASE SYNDROME 1
122 CYTOPENIA 1
123 DEFORMITY 1
124 DELUSION 1
125 DEPRESSION 1
126 DISORIENTATION 1
127 DRUG HYPERSENSITIVITY 1
128 DRY SKIN 1
129 DYSSTASIA 1
130 EARLY SATIETY 1
131 ERECTILE DYSFUNCTION 1
132 ERYTHEMA NODOSUM 1
133 EYE SWELLING 1
134 FEELING ABNORMAL 1
135 FEELING JITTERY 1
136 FOOD POISONING 1
137 FOREIGN BODY REACTION 1
138 GENOTYPE DRUG RESISTANCE TEST POSITIVE 1
139 GONORRHOEA 1
140 GUILLAIN-BARRE SYNDROME 1
141 HALLUCINATION 1
142 HEAD INJURY 1
143 HIP ARTHROPLASTY 1
144 HOT FLUSH 1
145 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 1
146 HYPERSENSITIVITY 1
147 HYPOMENORRHOEA 1
148 HYPOTENSION 1
149 IMPAIRED WORK ABILITY 1
150 INCISION SITE PAIN 1
151 INFLUENZA 1
152 INFLUENZA LIKE ILLNESS 1
153 INJECTION SITE MOVEMENT IMPAIRMENT 1
154 INJECTION SITE NECROSIS 1
155 INJECTION SITE NERVE DAMAGE 1
156 INJECTION SITE PAPULE 1
157 INJECTION SITE PUSTULE 1
158 INJECTION SITE VESICLES 1
159 INTENTIONAL UNDERDOSE 1
160 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1
161 JAUNDICE 1
162 LIPOSUCTION 1
163 MASS 1
164 MENTAL DISORDER 1
165 MUSCLE TIGHTNESS 1
166 MUSCULOSKELETAL DISORDER 1
167 NASAL CONGESTION 1
168 NASAL CRUSTING 1
169 NEEDLE ISSUE 1
170 NEURALGIA 1
171 NONSPECIFIC REACTION 1
172 ORAL HERPES 1
173 OROPHARYNGEAL GONOCOCCAL INFECTION 1
174 OROPHARYNGEAL PAIN 1
175 OSTEOPOROSIS 1
176 PALATAL DISORDER 1
177 PALLOR 1
178 PAPILLOMA VIRAL INFECTION 1
179 PAROSMIA 1
180 PERINEAL RASH 1
181 PROCTALGIA 1
182 PRODUCT ADMINISTERED BY WRONG PERSON 1
183 PRODUCT ADMINISTRATION INTERRUPTED 1
184 PRODUCT ADMINISTRATION ISSUE 1
185 PRODUCT COLOUR ISSUE 1
186 PRODUCT COMMUNICATION ISSUE 1
187 PRODUCT DISPENSING ISSUE 1
188 PRODUCT DOSE OMISSION IN ERROR 1
189 PRODUCT LABEL ISSUE 1
190 PRODUCT PREPARATION ISSUE 1
191 PRODUCT QUALITY ISSUE 1
192 PRODUCT SUBSTITUTION ISSUE 1
193 PRODUCT USE COMPLAINT 1
194 PYODERMA GANGRENOSUM 1
195 RASH PAPULAR 1
196 RASH PRURITIC 1
197 RECALLED PRODUCT ADMINISTERED 1
198 RECTAL DISCHARGE 1
199 RESTLESSNESS 1
200 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 1
201 RHABDOMYOLYSIS 1
202 RHINORRHOEA 1
203 SEIZURE LIKE PHENOMENA 1
204 SELF-CONSCIOUSNESS 1
205 SENSORY DISTURBANCE 1
206 SERUM SICKNESS-LIKE REACTION 1
207 SINUSITIS 1
208 SKIN MASS 1
209 SKIN WARM 1
210 SOFT TISSUE NECROSIS 1
211 STOMATITIS 1
212 SUICIDAL IDEATION 1
213 SYPHILIS 1
214 TACHYCARDIA 1
215 TACHYPNOEA 1
216 THERAPY CESSATION 1
217 THERAPY INTERRUPTED 1
218 UNRESPONSIVE TO STIMULI 1
219 UPPER-AIRWAY COUGH SYNDROME 1
220 URETHRAL DISCHARGE 1
221 VIRAL INFECTION 1
222 VIRAL LOAD INCREASED 1
223 VIRAL UPPER RESPIRATORY TRACT INFECTION 1
224 WOUND 1
225 YELLOW SKIN 1